Clinical gain from RT research
•
Delta outcome
–
Increase in TCP or OS
–
Decrease in toxicity
•
Delta patients
–
Eligibility of new patient groups for RT
–
Increase in number of patients in a patient group
•
Delta XX
–
Derivative effects of developments (such as new
technologies useful for wider scope of applications)